Health Catalyst to Participate in Upcoming Investor Conferences Nasdaq:HCAT


(MENAFN- GlobeNewsWire - Nasdaq) SOUTH JORDAN, Utah, Feb. 26, 2021 (GLOBE NEWSWIRE) -- Health Catalyst, Inc. ("Health Catalyst", Nasdaq: HCAT), a leading provider of data and analytics technology and services to healthcare organizations, today announced that Bryan Hunt, CFO and Adam Brown, SVP of Investor Relations and FP & A, will participate in the following upcoming investor conferences:

  • Raymond James & Associates' 42nd Annual Institutional Investors Conference on Wednesday, March 3, 2021, which will include a fireside chat presentation at 12:30 p.m. EST. An audio-only recording will be available at .
  • 2021 Truist Securities Technology, Internet & Services Conference on Tuesday, March 9, 2021.

About Health Catalyst

Health Catalyst is a leading provider of data and analytics technology and services to healthcare organizations committed to being the catalyst for massive, measurable, data-informed healthcare improvement. Its customers leverage the cloud-based data platform—powered by data from more than 100 million patient records and encompassing trillions of facts—as well as its analytics software and professional services expertise to make data-informed decisions and realize measurable clinical, financial, and operational improvements. Health Catalyst envisions a future in which all healthcare decisions are data informed.

Health Catalyst Investor Relations Contact:

Adam Brown
Senior Vice President, Investor Relations and FP & A
+1 (855)-309-6800

Health Catalyst Media Contact:

Amanda Hundt

+1 (575) 491-0974


MENAFN26022021004107003653ID1101667492


Legal Disclaimer:
MENAFN provides the information “as is” without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the provider above.